Publications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Biobizkaia (5)

2022

  1. E2f2 attenuates apoptosis of activated t lymphocytes and protects from immune‐mediated injury through repression of fas and fasl

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

  2. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity

    Cancers, Vol. 14, Núm. 19

2021

  1. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

2016

  1. LDLR and PCSK9 are associated with the presence of antiphospholipid antibodies and the development of thrombosis in aPLA carriers

    PLoS ONE, Vol. 11, Núm. 1

2015

  1. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution

    Cell Death and Differentiation, Vol. 22, Núm. 10, pp. 1577-1589